Considering that >80% of FGF9‐positive HCC show enhanced expression of FGFR3‐IIIb and/or FGFR3‐IIIc, FGF9 may exert strong effects in cells with upregulated FGFR3 variants. Here, FGF9 is linked to hepatocellular carcinoma.